Picture of Scynexis logo

SCYX — Scynexis News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Brief: Scynexis Issues A Voluntary Nationwide Recall Of Brexafemme Due To Potential For Cross Contamination

Sept 27 (Reuters) - SCYNEXIS Inc  SCYX.O :
    * SCYNEXIS ISSUES A VOLUNTARY NATIONWIDE RECALL OF
BREXAFEMME®
(IBREXAFUNGERP TABLETS) DUE TO POTENTIAL FOR CROSS CONTAMINATION
WITH A NON-ANTIBACTERIAL ß-LACTAM DRUG SUBSTANCE
    * TO DATE, CO HAS NOT RECEIVED ANY REPORTS OF ADVERSE EVENTS
ESTABLISHED TO BE DUE TO POSSIBLE BETA-LACTAM CROSS
CONTAMINATION.
    * SCYNEXIS WAS MADE AWARE OF POTENTIAL CROSS-CONTAMINATION
RISK

Source text for Eikon:  ID:nGNX21yV9y 
Further company coverage:  SCYX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Scynexis

See all news